Piper Sandler Increases Replimune Group (NASDAQ:REPL) Price Target to $22.00
Replimune Group (NASDAQ:REPL – Free Report) had its price objective upped by Piper Sandler from $14.00 to $22.00 in a report published on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also weighed in on REPL. JPMorgan Chase & Co. boosted their price objective on […]
Replimune Group (NASDAQ:REPL – Free Report) had its price objective upped by Piper Sandler from $14.00 to $22.00 in a report published on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also weighed in on REPL. JPMorgan Chase & Co. boosted their price objective on […]
